Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-FR Version v18-FR
Language French French
Date Updated 2019-02-01 2019-01-30
Drug Identification Number 02458934 02458934
Brand name MYLAN-DIVALPROEX MYLAN-DIVALPROEX
Common or Proper name DIVALPROEX DIVALPROEX
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients VALPROIC ACID VALPROIC ACID
Strength(s) 250MG 250MG
Dosage form(s) TABLET (ENTERIC-COATED) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100BT, 500 BT 100BT, 500 BT
ATC code N03AG N03AG
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-02-11 2019-02-11
Actual start date
Estimated end date 2019-02-15 2019-02-15
Actual end date 2019-02-01
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments